Thomas Cavanagh is the founder of Oxular. Oxular has raised $37M in total funding. Backed by Forbion, IP Group, NeoMed. Based in Oxford, UK.
Thomas Cavanagh is the Chief Executive Officer of Oxular, a retinal therapeutics development company. Oxular focuses on developing treatments for retinal diseases, including diabetic macular edema, retinoblastoma, and uveal melanoma, utilizing its proprietary Oxuspheres and Oxulumis technologies. The company has raised $37 million in funding.
Full founder directory · Investor directory · Company funding database · Fundraising library